Browsing Tag
American Society of Clinical Oncology
2 posts
Nuvalent (NUVL) brings full ALKOVE-1 dataset to ASCO 2026 oral session weeks after neladalkib FDA filing
Nuvalent (NUVL) brings pivotal ALKOVE-1 neladalkib data to ASCO 2026. Here's what the oral session means for its dual NDA strategy and ALK lung cancer treatment.
April 21, 2026
INOVIQ (ASX: IIQ) soars on breakthrough ovarian cancer test data at ASCO 2025
INOVIQ Ltd (ASX: IIQ) stock surged 47.73% after ASCO 2025 data showed 77% sensitivity, 99.6% specificity in ovarian cancer screening. Explore what's next for EXO-OC.
June 2, 2025